Wikidata

(Q64150827)

English

Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers

clinical trial

In more languages

Statements

title
Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Select Rare CNS Cancers (English)
0 references
medical condition
ependymoma
0 references
gliosarcoma
0 references
meningioma
0 references
medulloblastoma
0 references
teratoma
0 references
start time
13 July 2017
0 references
end time
31 December 2020
0 references
number of participants
180
0 references
minimum age
18 year
0 references
maximum age
99 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150827&oldid=1857572985"